PsyMuKB

PPI network (data source: BioGrid)

A gene is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the mean normalized expression(base 2 log of (TPM+1)) +1 in all brain tissue from GTEx v7 or BrainSpan data.

A protein is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the normalized expression (base 10 log of iBAQ intensity) ≥0.5 in at least one brain tissue from ProteomicsDB data. Otherwise, a gene or protein is determined as either with below-cutoff expressions or no available data.

	The queried gene/protein
	The interacting partner is expressed at mRNA-level
	The interacting partner is expressed at protein-level
	The interacting partner is expressed at both mRNA and protein level
	The interacting partner is with either below-cutoff expressions or no expression data at both mRNA and protein level
	The interacting partner is hit by coding DNMs
	Physical interaction between queried gene/protein and its partner
	Physical interaction between two interacting partners

Symbol A	GeneA coding DNM count	Symbol B	GeneB coding DNM count	Interaction detection method	Publication	Evidence
SCNN1B	1	NEDD4L	3	far western blotting, far western blotting, affinity chromatography technology, unspecified method, affinity chromatography technology, affinity chromatography technology, unspecified method, affinity chromatography technology	Harvey KF (2001), Rauh R (2006), Soundararajan R (2009), Itani OA (2003), Snyder PM (2004), Bhalla V (2006), Lott JS (2002), Itani OA (2005)	8
SCNN1B	1	USP8	7	affinity chromatography technology, affinity chromatography technology	Zhou R (2013), Zhou R (2013)	2
SCNN1A	1	SCNN1G	2	affinity chromatography technology	Buck TM (2017)	1
STX1A	2	SCNN1A	1	affinity chromatography technology	Berdiev BK (2004)	1
USP2	0	SCNN1A	1	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology	Oberfeld B (2011), Ruffieux-Daidie D (2008), Ruffieux-Daidie D (2008)	3
SCNN1G	2	EPN1	4	affinity chromatography technology, pull down	Wang H (2006), Wang H (2006)	2
SCNN1G	2	NEDD4	2	pull down, pull down, far western blotting, enzymatic study, affinity chromatography technology	Farr TJ (2000), McDonald FJ (2002), Harvey KF (2001), Woelk T (2006), Snyder PM (2001)	5
SCNN1B	1	EPN1	4	affinity chromatography technology, pull down	Wang H (2006), Wang H (2006)	2
WWP2	7	SCNN1A	1	pull down	McDonald FJ (2002)	1
STX1A	2	SCNN1G	2	affinity chromatography technology, pull down	Berdiev BK (2004), Berdiev BK (2004)	2
USP2	0	SCNN1G	2	affinity chromatography technology, affinity chromatography technology	Oberfeld B (2011), Ruffieux-Daidie D (2008)	2
SCNN1A	1	EPN1	4	affinity chromatography technology, pull down	Wang H (2006), Wang H (2006)	2
WWP2	7	SCNN1G	2	pull down	McDonald FJ (2002)	1
SCNN1B	1	SCNN1G	2	protein complementation assay	Faria D (2012)	1
SCNN1B	1	USP2	0	affinity chromatography technology	Ruffieux-Daidie D (2008)	1
COMMD1	1	SCNN1G	2	affinity chromatography technology	Biasio W (2004)	1
SCNN1A	1	NEDD4L	3	far western blotting, two hybrid, affinity chromatography technology, far western blotting, unspecified method, affinity chromatography technology, affinity chromatography technology, unspecified method, affinity chromatography technology, affinity chromatography technology	Harvey KF (2001), Malbert-Colas L (2003), Zhou R (2007), Rauh R (2006), Itani OA (2003), Snyder PM (2004), Bhalla V (2006), Lott JS (2002), Ruffieux-Daidie D (2008), Xu D (2015)	10
COMMD1	1	SCNN1B	1	affinity chromatography technology, affinity chromatography technology	Ke Y (2010), Biasio W (2004)	2
SCNN1B	1	NEDD4	2	pull down, pull down, far western blotting, enzymatic study, affinity chromatography technology, affinity chromatography technology, x-ray crystallography	Farr TJ (2000), McDonald FJ (2002), Harvey KF (2001), Persaud A (2009), Ke Y (2010), Snyder PM (2001), Kanelis V (2001)	7
AP1M2	2	SCNN1B	1	affinity chromatography technology	Wang H (2006)	1
AP1M2	2	SCNN1A	1	affinity chromatography technology	Wang H (2006)	1
SCNN1A	1	SERP1	0	protein complementation assay	Faria D (2012)	1
WWP2	7	SCNN1B	1	pull down, far western blotting	McDonald FJ (2002), Harvey KF (2001)	2
SOX4	5	SCNN1G	2	two hybrid	Jang SM (2015)	1
USP8	7	SCNN1G	2	affinity chromatography technology	Zhou R (2013)	1
STX1A	2	SCNN1B	1	affinity chromatography technology	Berdiev BK (2004)	1
SCNN1A	1	NEDD4	2	pull down, pull down, far western blotting, affinity chromatography technology, x-ray crystallography, x-ray crystallography, pull down	Farr TJ (2000), McDonald FJ (2002), Harvey KF (2001), Snyder PM (2001), Bobby R (2013), Panwalkar V (2016), Panwalkar V (2016)	7
AP1M2	2	SCNN1G	2	affinity chromatography technology	Wiemuth D (2007)	1
SCNN1G	2	NEDD4L	3	far western blotting, unspecified method, far western blotting, unspecified method, affinity chromatography technology, affinity chromatography technology, unspecified method	Harvey KF (2001), Nagaki K (2006), Rauh R (2006), Itani OA (2003), Snyder PM (2004), Bhalla V (2006), Lott JS (2002)	7
EPN1	4	AP1M2	2	affinity chromatography technology	Wang H (2006)	1
SCNN1B	1	SCNN1A	1	protein complementation assay, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology	Faria D (2012), Faria D (2012), Faria D (2012), Buck TM (2017)	4
SCNN1G	2	SERP1	0	protein complementation assay	Faria D (2012)	1
SCNN1A	1	USP8	7	affinity chromatography technology	Zhou R (2013)	1
CTSD	0	SCNN1G	2	biochemical	Wan C (2015)	1
SCNN1B	1	SERP1	0	protein complementation assay, affinity chromatography technology, affinity chromatography technology	Faria D (2012), Faria D (2012), Faria D (2012)	3